Evaluation on the Safety of Ticagrelor Among Chinese ACS Patients
NCT02430493 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1066
Last updated 2018-03-14
Summary
The primary objective is to describe the safety and tolerability of ticagrelor, by assessment of adverse events (characteristics, reporting rate, severity, relationship and risk factors), especially the bleeding events as defined in 8.1 and other serious adverse events (SAEs) during 1-year follow up in Chinese acute coronary syndrome (ACS) patients.
Conditions
- Acute Coronary Syndrome (ACS)
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Changsheng Ma · Beijing Anzhen Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 130 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-05-28
- Primary Completion
- 2017-03-29
- Completion
- 2017-03-29
Countries
- China
Study Locations
More Related Trials
-
Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCI
NCT04338919 ·Status: UNKNOWN ·Phase: NA
-
Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension
NCT02305680 ·Status: COMPLETED
-
Canadian Ticagrelor Survey
NCT01757483 ·Status: COMPLETED
-
Outcomes in UK ACS Patients Prescribed Ticagrelor
NCT03058601 ·Status: COMPLETED
-
Reversal of the Anti-platelet Effects of Ticagrelor
NCT02383771 ·Status: COMPLETED ·Phase: PHASE4
-
Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"
NCT02206815 ·Status: COMPLETED ·Phase: PHASE4
-
Patient Characteristics, Persistence to Treatment and Outcome Events in Patients Treated With Ticagrelor 60 mg After Myocardial Infarction in Real-world Clinical Practice
NCT04568083 ·Status: COMPLETED
-
Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable CAD Treated With Ticagrelor Monotherapy
NCT02219412 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Evolocumab on the Antiplatelet Effects of Ticagrelor and Aspirin in Patients With Acute Coronary Syndrome
NCT05418166 ·Status: UNKNOWN
-
Reversing Ticagrelor's Effects With Fresh Platelets
NCT02201394 ·Status: COMPLETED ·Phase: PHASE4
-
Low-dose Evaluation of Aspirin After STEMI Patients With PCI: A Multicenter, Double-blind, Randomized Controlled Clinical Trial
NCT06756945 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis
NCT02053909 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
NCT01225562 ·Status: COMPLETED ·Phase: PHASE3
-
ADHerence of ticagrelOr in Real World Patients With aCute Coronary Syndrome
NCT03129867 ·Status: COMPLETED
-
Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage
NCT05986968 ·Status: RECRUITING ·Phase: NA
-
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
NCT02293395 ·Status: COMPLETED ·Phase: PHASE2
-
Study to See if Platelet Transfusion Stop or Lessen the Effect of the Drug on Platelets
NCT01744288 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
NCT02291419 ·Status: TERMINATED ·Phase: PHASE4
-
Comparison of the Efficacy of Ticagrelor Combined With ASA to ASA Alone in Patients With Stroke
NCT04962451 ·Status: COMPLETED ·Phase: PHASE4
-
Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACS
NCT04739384 ·Status: COMPLETED ·Phase: PHASE3
-
Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG
NCT01755520 ·Status: TERMINATED ·Phase: PHASE3
-
Ticagrelor Pharmacokinetics in NSTEMI
NCT02292277 ·Status: COMPLETED
-
Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia
NCT01361386 ·Status: COMPLETED
-
Disparities in the Proportion of Ticagrelor and Prasugrel-eligible Patients with Acute Coronary Syndrome in a Real-world Registry
NCT05774431 ·Status: COMPLETED
-
THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death
NCT03354429 ·Status: COMPLETED ·Phase: PHASE3